Morphea en coup de sabre and hemifacial atrophy in an interdisciplinary approach


morphea en coup de sabre
progressive hemifacial atrophy
Parry‑Romberg syndrome
Romberg disease
facial asymmetry

How to Cite

Wróblewska A, Polańska A, Dańczak‑Pazdrowska A, Żaba R, Adamski Z, Metthews‑Brzozowska T, Wegner J. Morphea en coup de sabre and hemifacial atrophy in an interdisciplinary approach. JoFA [Internet]. 2020 Dec. 31 [cited 2023 Mar. 28];3(2):97-107. Available from:


The increase in the degree of fluctuation asymmetry is accompanied, among others, by diseases such as morphea en coup de sabre (morphea ECDS) or Parry‑Romberg syndrome (PHA). Patients suffering from them struggle not only with dermatological defects, but also with neurological, rheumatological, orthopedic, ophthalmological and dental symptoms. Morphological and functional disorders and craniofacial deformities related to them often generate psychosocial problems. The complexity of the issues to be solved proves the necessity of undertaking interdisciplinary actions aimed at developing objective diagnostic and therapeutic protocols, restoring (especially in pediatric patients) as close as possible to the correct developmental patterns, inhibiting the active phase of the disease and undertaking effective and aesthetically satisfying measures.


Debat V. Symmetry is beauty- or is it? Medicine /Science2016;32:


Agrawal R, Patel DP, Bhagyashree, Desai B. Correction of sever asymmetry: a case with fractured condyle. APOS Trends in Orthodontics.2019;9:59–64.

Niklander S, Marin C, Martinez R, Esguep A. Morphea en coup de sabre: an unusual oral presentation. J Clin Exp Dent. 2017;9:315–318.

Wong M, Phillips CD, Hagiwara M, Shatzkes DR. Parry-Romberg Syndrome: cases and literature review. Am J Neurol. 2015;36:1355–1361.

Khamaganova I. Progressive hemifacial atrophy and linear scleroderma en coup de sabre: a spectrum of the same disease? Frontiers in Medicine. 2018;4:258.

Wolska‑Gawron K, Krasowska D. Localized scleroderma‑classification and to ols for the evaluation of tissue damage and disease activity. Dermatol Rev. 2017,104:169–289.

Tolkachjov SN, Patel NG, Tollefson MM. Progressive hemifacial atrophy: a review. Orphanet Journal of Rare Diseases. 2015;10:39.

Lis‑Święty A, Janicka I, Skrzypek‑Salamon A, Brzezińska‑Wcisło L. A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients.J Eur Acad Dermatol Venereol. 2017;31:30–37.

Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L i wsp.. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol. 2017;31:1581–1594.

Arnold N, Shareef S, Sikorski L. A unique case of progressive hemi‑facial atrophy successfully treated with methotrexate. Spartan Medical Research Journal. 2017;1(2).

Abdelnour JGM, Abdelnour YGW, Kerollos RMAB, Mahmoud ZI. Parry- Romberg syndrome associated with en coup de sabre in a patient from South Sudan- a rare entiti from East Africa: a case report. J Med Case Rep. 2019;13:138.

Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM i wsp. Consensus‑based recommendations for the management of juvenile localised scleroderma. Ann Rheum Dis. 2019;78:1019–1024.

Martini G, Fandanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F. Disease course and long‑term outcome oj juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review. Autoimmun Rev. 2018;17:727–734.

Soltani AD, Tehranchi A, Safari S, Tehrani Z, Ghaffari S. Parry- Romberg syndrome: a case report of non‑invasive treatment. J Oral Health And Craniofac Sci. 2019;4:15–20.

Careta MF. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015;90:62–73.

Mertens JS, Seyger MB,Thurlings, Radstake RDJ, Jong EMGJ. Am J Clin Dermatol. 2017;18:491–512.

Asano Y, Fujimoto M, Ishikawa O, Sato S, Jinnin M, Takehawa H i wsp. Diagnostic criteria, severity classification and guidelines of localized scleroderma. J Dermatol. 2018;45:755–780.

Krasowska D, Rudnicka L, Dańczak-Pazdrowska A, Chodorowska G, Woźniacka A, Lis-Święty A, Czuwara J i wsp. Lokalized scleroderma (morphea). Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Przegl Dermatol. 2019;106,333–353.

Arif T, Majid I, Haji ML. Late onset en coup de sabre following trauma: rare presentation of a rare disease. Our Dermatol Online. 2015;6:49–51.

Aydin H, Yologlu Z, Sargin H, Metin MR. Parry- Romberg syndrome physical, clinical and imaging features. Neurosciences. 2015; 20:368–371.

Arif T, Adil M, Amin SS, Samil M, Raj D. Concomitant en coup de sabre and plaque morphea in the same patient: a rare occurrence. Dermatol Rev. 2017;104:1–5.

Szabo A, Mayor R. Cell traction in collective cell migration and morphogenesis: the chase and run mechanism.Cell Adhesion And Migration. 2015;9:380–383.

Graf D, Malik Z, Hayano S, Mishina Y. Common mechanisms in development and disease: BMP signaling in craniofacial development. Cytokine Growth Factor Rev. 2016;27:129–139.

Szabo A, Theveneau, Turan M, Mayor R. Neural crest streaming as an emergent property of tissue interactions during morphogenesis. PLoS Comput Biol. 2019;15: e1007002.

Torok KS, Li SC, Jacobe HM, Taber SH, Stevens AM, Zulian F, Lu TT. Immunopathogenesis of pediatric localized scleroderma. Front. Immunol.Vol. 10:908.

Reiff D, Crayne CB, Mannien ML, Cron RQ. Characteristics of coexistence localized scleroderma and inflammatory arthritis. Eur J Rheumatolol. 2020;7:67–71.

Stępień K, Reich A. Twardzina en coup de sabre. Forum Dermatologicum. 2018;4:153–154.

Vix J, Mathis S, Lacoste M, guillevin, Neau JP. Neurological manifestations in Parry‑Romberg syndrome:2 case reports. Medicine. 2015;94: e1147.

Śmiech‑Słomkowska G, Nawrocka A, Wójcicki P. Zmiany w układzie stomatognatycznym w przebiegu zespołu Parry’ego‑Romberga. Magazyn Stomatologiczny. 2017;7–8:72–80.

Anderson LE, Treat JR, Licht DJ, Kreiger PA, Knight AM. Remission of seizures with immunosuppressive therapy in Parry- Romberg syndrome and en coup de sabre linear scleroderma: Case report and brief review of the literature. Pediatr Dermatol. 2018;35:363–365.

English SW, Ho ML, Tollefson MM, Wong- Kisiel LC. Focal epilepsy in a teenager with facial atrophy and hair loss. SeminPediatrNeurol. 2018;26:68–73.

Duman IE, Ekinci G. Neuroimaging and clinical findings in a case if linear scleroderma en coup de sabre. Radiology Case Reports. 2018;13:545–548.

Allmendinger AM, Ricci JA, Desai NS, Viswanadhan N, Rodriguez D. Atypical neuroimaging manifestations of linear scleroderma en coup de sabre. Iran J Child Neurol. 2015;9:62–68.

Reschke R, Schuster V, Kunz M. Scleroderma en coup de sabre. Dtsch Arztebl. 2019;116:544.

Khan MA, Shaw L, Eleftheriou D, Prabhakar P, Chong WK, Glover M. Radiologic improvement after early medical intervention in localized facial morphea. Pediatr Dermatol. 2016;33,1–4.

Fea AM, Aragno V, Briamonte C, Franzone M, Putignano D, Grignolo FM. Parry‑Romberg syndrome with a wide range of ocular manifestations: a case report. BMC Ophtalmol. 2015;15:119.

Bucher F, Fricke J, Neugebauer A, Cursieven C, Heindi LM. Ophthalomological manifestations of Parry‑Romberg syndrome. Survey of Ophthalmology. 2016;61:693–701.

Keith TA, Tidmore E. The development of multiple ocular complications in a patient with Parry- Romberg syndrome. Clin Exp Optom. 2019;102:437–439.

Arnold N, Shareef S, Sikorski L. A unique case of progressive hemi- facial atrophy successfully treated with Methotrexate. Spartan Medical Research Journal. 2017;1(2).

Laxer RM, Miller S. Adie pupil as the initial presentation of localized en coup de sabre scleroderma. J Reumatol. 2017;44:1096–1097.

Deans JAB, Jones J,Merrett SJ. Dentofacial features of en coup de sabre- a case report. Dental Updates Orthodonties. 2017;44,9.

Van der Cruyssen F, Meeus J, Schcenaers J, Politis C. Parry‑Romberg syndrome: a longterm retrospective cohort study of 10 patients. Oral Maxillofac Surg Cas. 2018;4:73–83.

Wu EY, Li SC, Torok KS, Virkud YV, Fuhlbrigge RC, Rabinovich CE. Baseline description of the juvenile localized scleroderma subgroup from the Childchood Arthritis and Rheumatology Research Alliance Legacy Registry. ACR Open Rheumatology. 2019;1:119–124.

Li S, Zheng RJ. Overview of juvenile localized scleroderma and its management. J Pediatr. 2019;16:5–18.

Skrzypek- Salamon A, Lis‑Święty A, Ranosz‑Janicka I, Brzezińska‑Wcisło L. Localized scleroderma cutaneous assessment tool (LoSCAT) adapter for use in adult patients:report from an initial validation study. Health Qual Life Outcomes. 2018;16:185.

Tkachenko E, Cunningham MJ, O’Donnell, Levin AN. Adult- onset bilateral Parry‑Romberg syndrome. JAAD Case Rep. 2019;5:2019–212.

Kunzler E, Florez‑Pollack S, Teske N, O’Brien J, Prasad S, Jacobe H. Linear morphea: clinical characteristics, disease course and treatment of the morphea in adults and children cohort. J Am Acad Dermatol. 2019;80:1664–1670.

Araujo Franco JP, Lima RB, Martins CJ, Serra MS, D’Acri AM. Scleroderma en coup de sabre treated with polymethylmethacrylate- case report. An Bras Dermatol. 2016;91:209–211.

Atlas H, Gőnűl M, Gőkce A, Acar M, Gűrdal C. An overlap case of Parry‑Romberg syndrome and en coup de sabre with striking ocular involvement and anti‑double‑stranded DNA positivity. Indian J Ophtalmol. 2018;66:336–368.

Ardalan K, Zigler CK, Torok KS. Predictors of longitudinal quality of life in juvenile localized scleroderma. Arthritis Care and Research.2017;69:1082–1087.